Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discovery

Antiviral Research

Volumn 88, Issue 3, 2010, Pages 269-275

  Rhee, Soo Yon ^a   Margeridon Thermet, Severine ^a   Nguyen, Mindie H ^a   Liu, Tommy F ^a   Kagan, Ron M ^b   Beggel, Bastian ^c   Verheyen, Jens ^d   Kaiser, Rolf ^d   Shafer, Robert W ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^c MAX PLANCK INSTITUTE FOR INFORMATICS   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Database; Drug resistance mutation; Hepatitis B virus; Nucleoside and nucleotide RT inhibitors (NRTIs, NtRTIs); Reverse transcriptase (RT)

Indexed keywords

ADEFOVIR; LAMIVUDINE; NUCLEOSIDE ANALOG; RNA DIRECTED DNA POLYMERASE;

ARTICLE; DATA BASE; GENE SEQUENCE; GENOTYPE; HEPATITIS B VIRUS; HUMAN; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ADENINE; BASE SEQUENCE; DATABASES, GENETIC; DNA MUTATIONAL ANALYSIS; DNA, VIRAL; DRUG RESISTANCE, VIRAL; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; MOLECULAR SEQUENCE DATA; MULTILOCUS SEQUENCE TYPING; MUTATION; PHOSPHONIC ACIDS; REVERSE TRANSCRIPTASE INHIBITORS; RNA-DIRECTED DNA POLYMERASE;

HEPATITIS B VIRUS;

EID: 78650243279     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2010.09.012     Document Type: Article

References (19)

1. Bartholomeusz A., Tehan B.G., Chalmers D.K. Comparisons of the HBV and HIV polymerase, and antiviral resistance mutations. Antivir. Ther. 2004, 9:149-160.
2. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 1995, 57:289-300.
3. Das K., Xiong X., Yang H., Westland C.E., Gibbs C.S., Sarafianos S.G., Arnold E. Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC). J. Virol. 2001, 75:4771-4779.
4. Gnaneshan S., Ijaz S., Moran J., Ramsay M., Green J. HepSEQ: international public health repository for hepatitis B. Nucleic Acids Res. 2007, 35:D367-D370.
5. Günther S., Fischer L., Pult I., Sterneck M., Will H. Naturally occurring variants of hepatitis B virus. Adv. Virus Res. 1999, 52:25-137.
6. Keeffe E.B., Dieterich D.T., Han S.H., Jacobson I.M., Martin P., Schiff E.R., Tobias H. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin. Gastroenterol. Hepatol. 2008, 6:1315-1341.
7. Keeffe E.B., Dieterich D.T., Pawlotsky J.M., Benhamou Y. Chronic hepatitis B: preventing, detecting, and managing viral resistance. Clin. Gastroenterol. Hepatol. 2008, 6:268-274.
8. Kurbanov F., Tanaka Y., Mizokami M. Geographical and genetic diversity of the human hepatitis B virus. Hepatol. Res. 2010, 40:14-30.
9. Liu B.M., Li T., Xu J., Li X.G., Dong J.P., Yan P., Yang J.X., Yan L., Gao Z.Y., Li W.P., Sun X.W., Wang Y.H., Jiao X.J., Hou C.S., Zhuang H. Characterization of potential antiviral resistance mutations in hepatitis B virus reverse transcriptase sequences in treatment-naive Chinese patients. Antiviral Res. 2010, 85:512-519.
10. Lok A.S., McMahon B.J. Chronic hepatitis B: update 2009. Hepatology 2009, 50:661-662.
11. Lok A.S., Zoulim F., Locarnini S., Bartholomeusz A., Ghany M.G., Pawlotsky J.M., Liaw Y.F., Mizokami M., Kuiken C. Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology 2007, 46:254-265.
12. Ogata N., Fujii K., Takigawa S., Nomoto M., Ichida T., Asakura H. Novel patterns of amino acid mutations in the hepatitis B virus polymerase in association with resistance to lamivudine therapy in japanese patients with chronic hepatitis B. J. Med. Virol. 1999, 59:270-276.
13. Schaefer S., Magnius L., Norder H. Under construction: classification of hepatitis B virus genotypes and subgenotypes. Intervirology 2009, 52:323-325.
14. Schildgen O., Sirma H., Funk A., Olotu C., Wend U.C., Hartmann H., Helm M., Rockstroh J.K., Willems W.R., Will H., Gerlich W.H. Variant of hepatitis B virus with primary resistance to adefovir. N. Engl. J. Med. 2006, 354:1807-1812.
15. Shafer R.W., Jung D.R., Betts B.J. Human immunodeficiency virus type 1 reverse transcriptase and protease mutation search engine for queries. Nat. Med. 2000, 6:1290-1292.
16. Shaw T., Bartholomeusz A., Locarnini S. HBV drug resistance: mechanisms, detection and interpretation. J. Hepatol. 2006, 44:593-606.
17. Sheldon J., Camino N., Rodes B., Bartholomeusz A., Kuiper M., Tacke F., Nunez M., Mauss S., Lutz T., Klausen G., Locarnini S., Soriano V. Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir. Antivir. Ther. 2005, 10:727-734.
18. Shin I.T., Tanaka Y., Tateno Y., Mizokami M. Development and public release of a comprehensive hepatitis virus database. Hepatol. Res. 2008, 38:234-243.
19. Yuen L.K., Ayres A., Littlejohn M., Colledge D., Edgely A., Maskill W.J., Locarnini S.A., Bartholomeusz A. SeqHepB: a sequence analysis program and relational database system for chronic hepatitis B. Antiviral Res. 2007, 75:64-74.